Projected Income Statement: Evotec SE

Forecast Balance Sheet: Evotec SE

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 -345 -212 22.1 216 -27.7 143 162 173
Change - 38.55% 110.42% 877.38% -112.82% 616.95% 13.29% 6.79%
Announcement Date 12/04/22 12/05/23 24/04/24 17/04/25 08/04/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Evotec SE

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 118.9 181.4 213.3 117.5 72.54 65.6 72.07 75.02
Change - 52.47% 17.63% -44.93% -38.25% -9.57% 9.86% 4.1%
Free Cash Flow (FCF) 1 3.294 21.75 -176.9 -99.25 -81.72 -170.6 -56.97 7.433
Change - 560.35% -913.18% 43.89% 17.66% -108.7% 66.6% 113.05%
Announcement Date 12/04/22 12/05/23 24/04/24 17/04/25 08/04/26 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Evotec SE

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 17.36% 13.53% 8.49% 2.83% 5.21% -11.36% 6.58% 12.06%
EBIT Margin (%) 6.63% 2.77% -3.41% -17.88% -7.13% -43.11% -5.65% 3.31%
EBT Margin (%) 38.34% -20.49% -10.31% -24.34% -11.01% -33.79% -10.12% 3.35%
Net margin (%) 34.87% -23.38% -10.74% -24.6% -13.13% -39.33% -8.39% 1.83%
FCF margin (%) 0.53% 2.89% -22.64% -12.45% -10.37% -28.44% -7.92% 0.95%
FCF / Net Income (%) 1.53% -12.38% 210.79% 50.62% 78.94% 72.32% 94.36% 51.67%

Profitability

        
ROA 11.66% -7.82% -2.8% -6.78% -5.5% -21.12% -2.22% 1.64%
ROE 20.5% -13.7% -5.46% -6.08% -11.3% -28.44% -7.23% 3.22%

Financial Health

        
Leverage (Debt/EBITDA) - - 0.33x 9.57x - -2.1x 3.43x 1.83x
Debt / Free cash flow - - -0.12x -2.18x - -0.84x -2.85x 23.3x

Capital Intensity

        
CAPEX / Current Assets (%) 19.25% 24.13% 27.3% 14.74% 9.2% 10.94% 10.02% 9.56%
CAPEX / EBITDA (%) 110.85% 178.4% 321.5% 520.6% 176.5% -96.33% 152.36% 79.29%
CAPEX / FCF (%) 3,610.9% 833.73% -120.6% -118.36% -88.77% -38.46% -126.51% 1,009.25%

Items per share

        
Cash flow per share 1 0.7346 1.15 0.206 1.028 -0.0517 -1.122 0.2287 0.5471
Change - 56.49% -82.08% 398.83% -105.03% -2,070.11% 120.39% 139.24%
Dividend per Share 1 - - - - - - - -
Change - - - - - - - -
Book Value Per Share 1 7.812 6.718 6.32 1.189 4.582 3.605 2.97 2.932
Change - -14% -5.92% -81.19% 285.32% -21.33% -17.61% -1.28%
EPS 1 1.3 -0.99 -0.47 -1.11 -0.58 -1.173 -0.4303 -0.019
Change - -176.15% 52.53% -136.17% 47.75% -102.3% 63.33% 95.59%
Nbr of stocks (in thousands) 175,162 176,703 176,936 177,303 177,323 177,749 177,749 177,749
Announcement Date 12/04/22 12/05/23 24/04/24 17/04/25 08/04/26 - - -
1EUR
Estimates
2026 *2027 *
P/E -2.83x -7.72x
PBR 0.92x 1.12x
EV / Sales 1.22x 1.05x
Yield - -

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
3.320EUR
Average target price
4.586EUR
Spread / Average Target
+38.12%

Quarterly revenue - Rate of surprise